GHK-Cu is an endogenous copper tripeptide studied for collagen synthesis, gene expression, and skin regeneration.

What the GHK-Cu record establishes

GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex, a copper-binding tripeptide present in human plasma, saliva, and urine. In human fibroblast cultures it raises collagen synthesis dose-dependently, with the effect beginning between 10⁻¹² and 10⁻¹¹ M and peaking near 10⁻⁹ M, all without any change in cell number ^[1]. At the genome level, a Connectivity Map analysis reports that GHK alters expression of about 31.2% of human genes at a 50%-or-greater change threshold — 59% upregulated, 41% downregulated — with strong stimulation of the ubiquitin-proteasome system (41 genes up, 1 down) and of DNA-repair and antioxidant gene sets ^[2].

The sequence is not foreign to the body. GHK occurs within the alpha-2(I) chain of type I collagen and in SPARC/osteonectin, and is liberated during tissue injury. Plasma GHK falls from roughly 200 ng/mL (10⁻⁷ M) at age 20 to about 80 ng/mL by age 60 ^[3]. That decline, tracking the body's regenerative capacity, is the basis for treating GHK-Cu as a repair signal rather than a drug imposed from outside.

What the literature does NOT yet contain is large controlled human evidence. The strongest randomized signal is a 45-patient hair-loss trial of a 5-aminolevulinic-acid + GHK combination, not pure GHK-Cu ^[4]. Topical skin trials are small. No validated human pharmacokinetics exist for injectable or systemic use. This digest leads with the measured findings and marks the gaps as gaps.

GHK copper peptide: what the research describes

GHK-Cu mechanism of action rests on a dual identity. The GHK copper peptide is at once a copper chaperone and a signaling molecule. As a chaperone, it delivers copper(II) in a tightly bound 1:1 complex — stability constant log K around 16.4 — high enough to limit free-copper release while still enabling copper-dependent enzymes such as lysyl oxidase, which cross-links collagen and elastin, and superoxide dismutase, which clears free radicals ^[6].

As a signal, GHK-Cu instructs dermal fibroblasts to synthesize collagen, elastin, glycosaminoglycans, and the proteoglycan decorin, while rebalancing matrix metalloproteinases against their TIMP inhibitors so remodeling favors construction over breakdown ^[3][6]. A 2008 tissue-remodeling review catalogued the full profile: increased VEGF, FGF-2, NGF, and neurotrophins 3 and 4; suppression of TGF-beta-1, TNF-alpha, free radicals, and protein glycation; and chemoattraction of repair cells ^[6]. The breadth is the point — GHK copper peptide is studied as a coordinating signal, not a single-target agent.

Copper peptides and the GHK-Cu complex

The copper peptide class is small, and GHK-Cu is its most-studied member. A copper peptide is a short peptide chelated to a copper ion, where the copper is not a contaminant but a functional part of the molecule. In GHK-Cu, copper coordinates through the histidine imidazole nitrogen, the glycine alpha-amino nitrogen, and a deprotonated amide nitrogen, leaving the lysine side chain free ^[3].

That coordination matters: the free GHK peptide does not reproduce the copper complex's MMP-2 stimulation in fibroblast cultures, and copper binding is required for most documented tissue-repair activities ^[3]. The complex is also more stable than the free peptide, which plasma peptidases clear rapidly to the dipeptide histidyl-lysine after intravenous dosing in rats ^[10]. Within the copper-peptide family, GHK-Cu is the form with the deepest mechanistic and clinical record — explored further in copper peptide benefits and copper peptide skin research.

Anchored questions

What is copper peptide chemistry, in one definition?

A copper peptide is a short amino-acid chain bound to a copper(II) ion, where the copper is integral to the molecule's activity. GHK-Cu — glycyl-histidyl-lysine chelated 1:1 to copper — is the archetype. The copper enables cross-linking and antioxidant enzymes, and copper coordination is required for most of GHK-Cu's documented matrix-remodeling effects in fibroblast studies ^[3].

Copper Tripeptide-1: the cosmetic-ingredient name for GHK-Cu

Copper Tripeptide-1 is the INCI (cosmetic-ingredient) name for GHK-Cu. The two terms denote the same molecule — glycyl-L-histidyl-L-lysine copper(II), CAS 89030-95-5, molecular weight 402.92 Da. Skincare labels use "Copper Tripeptide-1" to declare copper-peptide content; the research literature uses "GHK-Cu." Topical Copper Tripeptide-1 carries a long cosmetic safety record, whereas injectable or systemic GHK-Cu is unapproved and research-only.

Is GHK-Cu peptide really anti-aging?

Research frames GHK-Cu as a gene-modulation and matrix-synthesis agent rather than a cosmetic claim. A 2015 review reports topical GHK-Cu increased procollagen production in 70% of treated subjects, versus 50% for vitamin C and 40% for retinoic acid ^[3], and aged-fibroblast work shows reversal of senescence markers p21 and p53 ^[15]. The evidence is mostly in vitro, rodent, and small topical-trial scale — strong on mechanism, thin on large controlled human outcomes.

Why does GHK decline with age?

Plasma GHK falls from approximately 200 ng/mL (10⁻⁷ M) at age 20 to about 80 ng/mL by age 60 ^[3][7]. The decline parallels the body's reduced regenerative capacity, which is the basis for the age-related-decline hypothesis: as the endogenous repair signal drops, so does the matrix-renewal program it drives. The causal direction is not fully resolved in the literature.

What is the GHK-Cu mechanism of action?

GHK-Cu acts as both a copper chaperone and a signaling molecule. At picomolar-to-nanomolar levels it stimulates fibroblast collagen, elastin, and glycosaminoglycan synthesis, rebalances MMPs against TIMPs, and the copper ion supports lysyl-oxidase cross-linking and SOD-like antioxidant activity, while broadly modulating gene expression ^[2][6]. The GHK-Cu mechanism of action is detailed on the research page.

What does a GHK-Cu peptide do?

In research models GHK-Cu stimulates synthesis of collagen, elastin, glycosaminoglycans, and decorin; modulates matrix-remodeling enzymes; supports angiogenesis via VEGF and FGF-2; and acts as an antioxidant copper carrier across wound, skin, and tissue-repair studies ^[3][6]. Its documented activity is coordinated tissue repair, observed mostly in vitro and in rodents.

What is GHK-Cu and how does it work?

GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex, an endogenous copper-binding tripeptide. It works by chaperoning copper and signaling fibroblasts and other cells to remodel the extracellular matrix, while shifting broad gene-expression programs toward repair, DNA fidelity, and antioxidant defense ^[2][6]. Copper coordination is required for most of these effects.

What is the difference between GHK and GHK-Cu?

GHK is the free tripeptide (MW 340.38, CAS 49557-75-7); GHK-Cu is the copper(II) chelate (MW 402.92, CAS 89030-95-5). Copper coordination is required for most documented tissue-repair activities — the free peptide does not reproduce MMP-2 stimulation in fibroblast cultures ^[3]. The literature frequently conflates the two forms, so the form a given study used always matters.